Embedded Files
Thrombosis refers development of blood clots, specifically, deep vein thrombosis (DVT) and pulmonary embolism (PE). Patients with certain types of cancers/treatment regimens are at a greater risk of a thromboembolic event.
Tools + Resources
Tools + Resources
Canadian guidelines for management of thrombosis in cancer patients
Summary of studies and treatment algorithm
Assess whether your patient meets criteria for AUD
Student Guide
Student Guide
Thrombosis.docxTest Your Knowledge
Test Your Knowledge
Which of the following is NOT a risk factor for cancer-associated thrombosis?
a) Immobilization
b) African american race
c) Older age
d) Low pre-chemotherapy platelet count (<350 x 109/L)
The following are signs/symptoms consistent with a pulmonary embolism EXCEPT?
a) Shortness of breath
b) Hemoptysis
c) Bradycardia
d) Syncope
What is the first line agent for cancer-associated thrombosis (assuming no contraindications etc.)?
a) LMWH
b) DOAC
c) Warfarin
d) None of the above
What is the typical duration of anticoagulant therapy for cancer-associated thrombosis?
a) 1 month
b) 3 months
c) 6 months
d) Indefintely
What is the preferred agent for treatment of cancer-associated thrombosis in patients with renal dysfunction?
a) LMWH
b) DOAC
c) Warfarin
d) None of the above
Answer Key
Answer Key
d
c
a
c
c
Page updated
Google Sites
Report abuse